• letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: SWOG From: eurekalert.org A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to new research results presented at the American Association for Cancer Research Annual Meeting 2019, held March 29-April 3 in Atlanta. Results from the SWOG Cancer Research Network trial known as DART, short for Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors, show ...
    The post Immunotherapy combination effective for patients with rare neuroendocrine cancer appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Fabio Bergamin From: medicalxpress.com T cells become active in the body only when they recognise a peptide located on one of the immune system’s sentinel cells. The ETH scientists repurposed sentinel cells in such a way that they indicate which peptides the T cells recognise. Medicine has great hopes for personalised cancer immunotherapy. The idea is to have a ...
    The post Major step towards individual cancer immunotherapy appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Something special seems to happen every year when Easter arrives. The focus on furry bunnies and fuzzy ducks and lots of candy always puts a smile on everyone’s face. Just the idea of the kids running around looking for treats at the seasonal Easter egg hunt can elicit delight from even the saddest people. So what is really at work ...
    The post The Spirit of Easter appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: Globe Newswire From: apnews.co Median overall survival was 21.9 months for highest vaccine dose vs. 14.6 months in published standard of care studies Median progression-free survival was 10.4 months vs. 6.9 and 5.4 months in published standard of care studies Imvax, Inc., a clinical-stage biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies, today announced ...
    The post Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Bonnie Annis From: curetoday.com Are you dense? I’m not referring to your mental abilities, I’m referring to your breasts. Have you felt them lately? I’m very concerned with your answer and so is the Food and Drug Administration (FDA), it seems. For the first time in over 20 years, the FDA feels amendments to current regulations would not only improve ...
    The post Are You Dense? appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: University of Geneva From: medicalxpress.com Of the three major subtypes of breast cancer, triple negative is the most lethal. Half of all breast cancer deaths are attributed to it, whereas it accounts for only about 15 percent of incidences of breast cancer. And unlike other breast cancers, it is resistant to most existing therapies. By studying the properties of ...
    The post Public domain antibiotic found highly effective against triple-negative breast cancer appeared first on Let Life Happen.